Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Living with phenylketonuria in adulthood: The PKU ATTITUDE study.

Cazzorla C, Bensi G, Biasucci G, Leuzzi V, Manti F, Musumeci A, Papadia F, Stoppioni V, Tummolo A, Vendemiale M, Polo G, Burlina A.

Mol Genet Metab Rep. 2018 Jul 11;16:39-45. doi: 10.1016/j.ymgmr.2018.06.007. eCollection 2018 Sep.

2.

Rapunzel syndrome: an infrequent cause of severe iron deficiency anemia and abdominal pain presenting to the pediatric emergency department.

Cannalire G, Conti L, Celoni M, Grassi C, Cella A, Bensi G, Capelli P, Biasucci G.

BMC Pediatr. 2018 Apr 4;18(1):125. doi: 10.1186/s12887-018-1097-8.

3.

Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.

Chiarot E, Spagnuolo A, Maccari S, Naimo E, Acquaviva A, Cecchi R, Galletti B, Fabbrini M, Mori E, Ruggiero P, Grandi G, Fontana MR, Bensi G, Margarit I.

Sci Rep. 2018 Feb 7;8(1):2593. doi: 10.1038/s41598-018-20609-5.

4.

Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to Bordetella pertussis Adhesion to Epithelial Cells.

Gasperini G, Biagini M, Arato V, Gianfaldoni C, Vadi A, Norais N, Bensi G, Delany I, Pizza M, Aricò B, Leuzzi R.

Mol Cell Proteomics. 2018 Feb;17(2):205-215. doi: 10.1074/mcp.RA117.000045. Epub 2017 Dec 4.

5.

Development of a Click Beetle Luciferase Reporter System for Enhanced Bioluminescence Imaging of Listeria monocytogenes: Analysis in Cell Culture and Murine Infection Models.

Ur Rahman S, Stanton M, Casey PG, Spagnuolo A, Bensi G, Hill C, Francis KP, Tangney M, Gahan CGM.

Front Microbiol. 2017 Sep 26;8:1797. doi: 10.3389/fmicb.2017.01797. eCollection 2017.

6.

In Vivo Analysis of Staphylococcus aureus-Infected Mice Reveals Differential Temporal and Spatial Expression Patterns of fhuD2.

Bacconi M, Haag AF, Chiarot E, Donato P, Bagnoli F, Delany I, Bensi G.

Infect Immun. 2017 Sep 20;85(10). pii: e00270-17. doi: 10.1128/IAI.00270-17. Print 2017 Oct.

7.

Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens.

Maruggi G, Chiarot E, Giovani C, Buccato S, Bonacci S, Frigimelica E, Margarit I, Geall A, Bensi G, Maione D.

Vaccine. 2017 Jan 5;35(2):361-368. doi: 10.1016/j.vaccine.2016.11.040. Epub 2016 Dec 7.

8.

Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination.

Corrado A, Donato P, Maccari S, Cecchi R, Spadafina T, Arcidiacono L, Tavarini S, Sammicheli C, Laera D, Manetti AG, Ruggiero P, Galletti B, Nuti S, De Gregorio E, Bertholet S, Seubert A, Bagnoli F, Bensi G, Chiarot E.

Sci Rep. 2016 Nov 30;6:38043. doi: 10.1038/srep38043.

9.

One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.

Mancini F, Monaci E, Lofano G, Torre A, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Galletti B, Laera D, Pallaoro M, Tuscano G, Fontana MR, Bensi G, Grandi G, Rossi-Paccani S, Nuti S, Rappuoli R, De Gregorio E, Bagnoli F, Soldaini E, Bertholet S.

PLoS One. 2016 Jan 26;11(1):e0147767. doi: 10.1371/journal.pone.0147767. eCollection 2016.

10.

A stable luciferase reporter plasmid for in vivo imaging in murine models of Staphylococcus aureus infections.

Bacconi M, Haag AF, Torre A, Castagnetti A, Chiarot E, Delany I, Bensi G.

Appl Microbiol Biotechnol. 2016 Apr;100(7):3197-206. doi: 10.1007/s00253-015-7229-2. Epub 2015 Dec 21.

PMID:
26685857
11.

MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.

Monaci E, Mancini F, Lofano G, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Giraldi M, Galletti B, Rossi Paccani S, Torre A, Fontana MR, Grandi G, de Gregorio E, Bensi G, Chiarot E, Nuti S, Bagnoli F, Soldaini E, Bertholet S.

Front Immunol. 2015 Sep 7;6:439. doi: 10.3389/fimmu.2015.00439. eCollection 2015.

12.

Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.

Torre A, Bacconi M, Sammicheli C, Galletti B, Laera D, Fontana MR, Grandi G, De Gregorio E, Bagnoli F, Nuti S, Bertholet S, Bensi G.

Infect Immun. 2015 Aug;83(8):3157-63. doi: 10.1128/IAI.00258-15. Epub 2015 May 26.

13.

Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.

Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG, Lofano G, Marchi S, Galletti B, Mariotti P, Bacconi M, Torre A, Maccari S, Scarselli M, Rinaudo CD, Inoshima N, Savino S, Mori E, Rossi-Paccani S, Baudner B, Pallaoro M, Swennen E, Petracca R, Brettoni C, Liberatori S, Norais N, Monaci E, Bubeck Wardenburg J, Schneewind O, O'Hagan DT, Valiante NM, Bensi G, Bertholet S, De Gregorio E, Rappuoli R, Grandi G.

Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):3680-5. doi: 10.1073/pnas.1424924112. Epub 2015 Mar 9.

14.

Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.

Fantappiè L, de Santis M, Chiarot E, Carboni F, Bensi G, Jousson O, Margarit I, Grandi G.

J Extracell Vesicles. 2014 Aug 11;3. doi: 10.3402/jev.v3.24015. eCollection 2014.

15.

SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains.

Nesta B, Valeri M, Spagnuolo A, Rosini R, Mora M, Donato P, Alteri CJ, Del Vecchio M, Buccato S, Pezzicoli A, Bertoldi I, Buzzigoli L, Tuscano G, Falduto M, Rippa V, Ashhab Y, Bensi G, Fontana MR, Seib KL, Mobley HL, Pizza M, Soriani M, Serino L.

PLoS Pathog. 2014 May 8;10(5):e1004124. doi: 10.1371/journal.ppat.1004124. eCollection 2014 May. Erratum in: PLoS Pathog. 2015 Mar;11(3):e1004773.

16.

SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion.

Gallotta M, Gancitano G, Pietrocola G, Mora M, Pezzicoli A, Tuscano G, Chiarot E, Nardi-Dei V, Taddei AR, Rindi S, Speziale P, Soriani M, Grandi G, Margarit I, Bensi G.

Infect Immun. 2014 Jul;82(7):2890-901. doi: 10.1128/IAI.00064-14. Epub 2014 Apr 28.

17.

Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence.

Chiarot E, Faralla C, Chiappini N, Tuscano G, Falugi F, Gambellini G, Taddei A, Capo S, Cartocci E, Veggi D, Corrado A, Mangiavacchi S, Tavarini S, Scarselli M, Janulczyk R, Grandi G, Margarit I, Bensi G.

MBio. 2013 Jan 8;4(1):e00387-12. doi: 10.1128/mBio.00387-12.

18.

Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.

Fagnocchi L, Biolchi A, Ferlicca F, Boccadifuoco G, Brunelli B, Brier S, Norais N, Chiarot E, Bensi G, Kroll JS, Pizza M, Donnelly J, Giuliani MM, Delany I.

Infect Immun. 2013 Feb;81(2):560-9. doi: 10.1128/IAI.01085-12. Epub 2012 Dec 10.

19.

Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.

Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti AG, Donato P, Swennen E, Gallotta M, Garibaldi M, Pinto V, Chiappini N, Musser JM, Janulczyk R, Mariani M, Scarselli M, Telford JL, Grifantini R, Norais N, Margarit I, Grandi G.

Mol Cell Proteomics. 2012 Jun;11(6):M111.015693. doi: 10.1074/mcp.M111.015693. Epub 2012 Jan 27.

20.

Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate.

Kabanova A, Margarit I, Berti F, Romano MR, Grandi G, Bensi G, Chiarot E, Proietti D, Swennen E, Cappelletti E, Fontani P, Casini D, Adamo R, Pinto V, Skibinski D, Capo S, Buffi G, Gallotta M, Christ WJ, Campbell AS, Pena J, Seeberger PH, Rappuoli R, Costantino P.

Vaccine. 2010 Dec 10;29(1):104-14. doi: 10.1016/j.vaccine.2010.09.018. Epub 2010 Sep 24.

PMID:
20870056
21.

Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.

Bombaci M, Grifantini R, Mora M, Reguzzi V, Petracca R, Meoni E, Balloni S, Zingaretti C, Falugi F, Manetti AG, Margarit I, Musser JM, Cardona F, Orefici G, Grandi G, Bensi G.

PLoS One. 2009 Jul 22;4(7):e6332. doi: 10.1371/journal.pone.0006332.

22.

Scavenger receptor gp340 aggregates group A streptococci by binding pili.

Edwards AM, Manetti AG, Falugi F, Zingaretti C, Capo S, Buccato S, Bensi G, Telford JL, Margarit I, Grandi G.

Mol Microbiol. 2008 Jun;68(6):1378-94. doi: 10.1111/j.1365-2958.2008.06220.x. Epub 2008 Apr 29.

23.

Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation.

Manetti AG, Zingaretti C, Falugi F, Capo S, Bombaci M, Bagnoli F, Gambellini G, Bensi G, Mora M, Edwards AM, Musser JM, Graviss EA, Telford JL, Grandi G, Margarit I.

Mol Microbiol. 2007 May;64(4):968-83.

24.

Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.

Rodríguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, Mora M, Scarselli M, Doro F, Ferrari G, Garaguso I, Maggi T, Neumann A, Covre A, Telford JL, Grandi G.

Nat Biotechnol. 2006 Feb;24(2):191-7. Epub 2006 Jan 15.

PMID:
16415855
25.

Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens.

Mora M, Bensi G, Capo S, Falugi F, Zingaretti C, Manetti AG, Maggi T, Taddei AR, Grandi G, Telford JL.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15641-6. Epub 2005 Oct 13.

26.

Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.

Capo S, Nuti S, Scarselli M, Tavarini S, Montigiani S, Mori E, Finco O, Abrignani S, Grandi G, Bensi G.

Vaccine. 2005 Oct 10;23(42):5028-37. Erratum in: Vaccine. 2007 Apr 30;25(17):3516.

PMID:
15982792
28.

Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial).

Bellia V, Foresi A, Bianco S, Grassi V, Olivieri D, Bensi G, Volonté M; BREATH Italian Study Group.

Respir Med. 2002 Nov;96(11):881-9.

29.

Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.

Buonamassa DT, Greer CE, Capo S, Yen TS, Galeotti CL, Bensi G.

Virology. 2002 Feb 15;293(2):335-44.

30.

Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes.

Carraresi L, Tripodi SA, Mulder LC, Bertini S, Nuti S, Schuerfeld K, Cintorino M, Bensi G, Rossini M, Mora M.

Oncogene. 2001 Dec 6;20(56):8148-53.

31.

The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles.

Greer CE, Petracca R, Buonamassa DT, Di Tommaso A, Gervase B, Reeve RL, Ugozzoli M, Van Nest G, De Magistris MT, Bensi G.

Vaccine. 2000 Dec 8;19(9-10):1008-12.

PMID:
11137233
32.

Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.

Heile JM, Fong YL, Rosa D, Berger K, Saletti G, Campagnoli S, Bensi G, Capo S, Coates S, Crawford K, Dong C, Wininger M, Baker G, Cousens L, Chien D, Ng P, Archangel P, Grandi G, Houghton M, Abrignani S.

J Virol. 2000 Aug;74(15):6885-92.

33.

Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapy.

Patoia L, Del Favero A, Giglietti A, Malacarne P, Donati D, Indelli M, Bensi G, Palladino MA, Cigarini P, Kempe R, Voigt T.

Clin Oncol (R Coll Radiol). 1999;11(2):99-104.

PMID:
10378635
34.

Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.

Lazzaroni M, Sangaletti O, Bargiggia S, Bensi G, Canali A, Bianchi Porro G.

Aliment Pharmacol Ther. 1996 Apr;10(2):187-91.

PMID:
8730248
35.
36.

Double-blind randomized, multicenter study comparing aluminium phosphate gel with rantitidine in the short-term treatment of duodenal ulcer.

Parente F, Bianchi Porro G, Canali A, Bensi G.

Hepatogastroenterology. 1995 Apr;42(2):95-9.

PMID:
7672773
37.

Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.

Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, et al.

Mol Cell Biol. 1993 Oct;13(10):6231-40.

38.

Loop substitution as a tool to identify active sites of interleukin-1 beta.

Palla E, Bensi G, Solito E, Buonamassa DT, Fassina G, Raugei G, Spano F, Galeotti C, Mora M, Domenighini M, et al.

J Biol Chem. 1993 Jun 25;268(18):13486-92.

39.

Operative arthroscopy of the ankle.

Cerulli G, Caraffa A, Buompadre V, Bensi G.

Arthroscopy. 1992;8(4):537-40.

PMID:
1466718
40.

An inducible enhancer controls the expression of the human interleukin 1 beta gene.

Bensi G, Mora M, Raugei G, Buonamassa DT, Rossini M, Melli M.

Cell Growth Differ. 1990 Oct;1(10):491-7.

41.
42.

Differential expression of the human IL-1 alpha and beta genes.

Mora M, Carinci V, Bensi G, Raugei G, Buonamassa DT, Melli M.

Prog Clin Biol Res. 1990;349:205-16. Review. No abstract available.

PMID:
2204929
43.

Treatment of chronic erosive gastritis: a double-blind trial of pirenzepine and cimetidine.

Dal Monte PR, D'Imperio N, Barillari A, Vezzadini P, Bensi G, Imbimbo BP.

Clin Ther. 1989 Nov-Dec;11(6):762-7.

PMID:
2692820
44.

[Effect of cimetropium bromide in the treatment of colic in the first 3 months of life. Randomized study].

Gomirato G, Bonomi A, Bensi G, Crosato M.

Minerva Pediatr. 1989 May;41(5):259-62. Italian.

PMID:
2796881
45.

Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease.

Mazzanti R, Moscarella S, Bensi G, Altavilla E, Gentilini P.

Alcohol Alcohol. 1989;24(2):121-8.

PMID:
2719769
46.

[Role of the liver in the metabolism of essential trace elements].

Cotrozzi G, Relli P, Mazzanti R, Lupi R, Bensi G.

Clin Ter. 1987 May 15;121(3):229-38. Review. Italian. No abstract available.

PMID:
2956014
47.

Human interleukin-1 beta gene.

Bensi G, Raugei G, Palla E, Carinci V, Tornese Buonamassa D, Melli M.

Gene. 1987;52(1):95-101.

PMID:
2954882
48.

The genome of Bacillus subtilis phage SPP1: structure of an early promoter.

Tailor R, Bensi G, Morelli G, Canosi U, Trautner TA.

J Gen Microbiol. 1985 May;131(5):1259-62.

PMID:
2991424
49.

Structure and expression of the human haptoglobin locus.

Bensi G, Raugei G, Klefenz H, Cortese R.

EMBO J. 1985 Jan;4(1):119-26.

50.

Molecular evidence of triplication in the haptoglobin Johnson variant gene.

Oliviero S, DeMarchi M, Carbonara AO, Bernini LF, Bensi G, Raugei G.

Hum Genet. 1985;71(1):49-52.

PMID:
2993157

Supplemental Content

Support Center